How can a pharmacist integrate with care coordination to reduce adverse drug events?

How can a pharmacist integrate with care coordination to reduce adverse drug events?

• A. By prescribing new medications without team input.
• B. By performing medication reconciliation, reviewing therapy for interactions, and communicating changes across the team.
• C. By limiting communication to the prescribing clinician only.
• D. By focusing solely on dispensing medications.

Answer: (B)

The main idea is that preventing adverse drug events hinges on the pharmacist actively managing medications across the care continuum and sharing information with the entire team. Medication reconciliation during transitions ensures the patient’s current, intended regimen is accurate, complete, and consistent with what they were taking before, catching omissions, duplications, or dosing errors that can lead to harm. Reviewing therapy for interactions involves checking all drugs for potential interactions, contraindications, or duplications—considering prescriptions, over-the-counter meds, and supplements—and adjusting as needed before problems occur. Communicating changes across the team guarantees that physicians, nurses, other pharmacists, and care coordinators are all informed and aligned, with clear rationale and updated notes in the chart so everyone implements the same plan. This integrated approach creates a safety net that helps prevent ADEs at every handoff and during ongoing care. Choices that focus only on prescribing without team input, restricting communication to one clinician, or concentrating solely on dispensing miss these critical clinical and collaborative steps that truly reduce adverse drug events.

The main idea is that preventing adverse drug events hinges on the pharmacist actively managing medications across the care continuum and sharing information with the entire team. Medication reconciliation during transitions ensures the patient’s current, intended regimen is accurate, complete, and consistent with what they were taking before, catching omissions, duplications, or dosing errors that can lead to harm. Reviewing therapy for interactions involves checking all drugs for potential interactions, contraindications, or duplications—considering prescriptions, over-the-counter meds, and supplements—and adjusting as needed before problems occur. Communicating changes across the team guarantees that physicians, nurses, other pharmacists, and care coordinators are all informed and aligned, with clear rationale and updated notes in the chart so everyone implements the same plan. This integrated approach creates a safety net that helps prevent ADEs at every handoff and during ongoing care. Choices that focus only on prescribing without team input, restricting communication to one clinician, or concentrating solely on dispensing miss these critical clinical and collaborative steps that truly reduce adverse drug events.